Fair Value Measurements - Narrative (Details) |
3 Months Ended | 6 Months Ended |
---|---|---|
Jun. 30, 2021
USD ($)
|
Jun. 30, 2021
USD ($)
|
|
Select operating assets and intellectual property of Myriad Autoimmune business unit and Myriad RBM, Inc | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Impairment on asset group held for sale | $ 0 | |
Level 3 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Estimated fair value of long-term debt | $ 106,000,000.0 | $ 106,000,000.0 |
Level 3 | Measurement input, expected term | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Measurement period for earn out liability | 14 years |